BG99197A - Means for the treatment of cataract and method for its preparation - Google Patents

Means for the treatment of cataract and method for its preparation

Info

Publication number
BG99197A
BG99197A BG99197A BG9919794A BG99197A BG 99197 A BG99197 A BG 99197A BG 99197 A BG99197 A BG 99197A BG 9919794 A BG9919794 A BG 9919794A BG 99197 A BG99197 A BG 99197A
Authority
BG
Bulgaria
Prior art keywords
cataract
treatment
methyl
preparation
relates
Prior art date
Application number
BG99197A
Other languages
Bulgarian (bg)
English (en)
Inventor
Mitsuyoshi Azuma
Yoshimasa Abe
Shunji Sogo
Original Assignee
Senju Pharmaceutical Co.,Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co.,Ltd. filed Critical Senju Pharmaceutical Co.,Ltd.
Publication of BG99197A publication Critical patent/BG99197A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/48—Compounds containing oxirane rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
BG99197A 1992-05-20 1994-11-18 Means for the treatment of cataract and method for its preparation BG99197A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP12767292 1992-05-20
PCT/JP1993/000643 WO1993023032A1 (fr) 1992-05-20 1993-05-17 Remede contre la cataracte et procede de production associe

Publications (1)

Publication Number Publication Date
BG99197A true BG99197A (en) 1995-08-28

Family

ID=14965866

Family Applications (1)

Application Number Title Priority Date Filing Date
BG99197A BG99197A (en) 1992-05-20 1994-11-18 Means for the treatment of cataract and method for its preparation

Country Status (10)

Country Link
EP (1) EP0641563A4 (pl)
CN (1) CN1084061A (pl)
BG (1) BG99197A (pl)
BR (1) BR9306387A (pl)
CA (1) CA2135302A1 (pl)
HU (1) HUT71250A (pl)
MX (1) MX9302924A (pl)
PL (1) PL171704B1 (pl)
RU (1) RU94046058A (pl)
WO (1) WO1993023032A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001206850A (ja) * 2000-01-25 2001-07-31 Kuraray Co Ltd 眼組織再生誘導剤
JPWO2003078415A1 (ja) 2002-03-15 2005-07-14 千寿製薬株式会社 環状ヘミアセタール誘導体およびその用途
ATE473216T1 (de) 2002-03-29 2010-07-15 Senju Pharma Co Hydroxymorpholinonderivat und dessen medizinische verwendung
AU2003248059A1 (en) 2002-07-22 2004-02-09 Senju Pharmaceutical Co., Ltd. NOVEL Alpha-KETOAMIDE DERIVATIVE AND USE THEREOF
JP2013513622A (ja) 2009-12-14 2013-04-22 ユニバーシティ オブ マサチューセッツ 白内障及び老眼を阻害する方法
PE20151747A1 (es) * 2013-03-14 2015-12-18 Univ Massachusetts Metodo para inhibir cataratas y presbicia
MX376641B (es) 2015-11-13 2025-03-07 Univ Massachusetts Moléculas bifuncionales que contienen peg para uso en la inhibición de cataratas y presbicia.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55115878A (en) * 1979-02-27 1980-09-06 Taisho Pharmaceut Co Ltd Epoxysuccinic acid derivative
JPS62255423A (ja) * 1986-04-26 1987-11-07 Taisho Pharmaceut Co Ltd 急性中枢神経損傷治療剤
JP2515119B2 (ja) * 1987-04-20 1996-07-10 日本ケミフア株式会社 ピペラジン誘導体を含有する活性酸素産生抑制ならびに活性酸素除去作用を有する医薬組成物

Also Published As

Publication number Publication date
BR9306387A (pt) 1998-09-15
WO1993023032A1 (fr) 1993-11-25
RU94046058A (ru) 1996-10-20
CA2135302A1 (en) 1993-11-25
EP0641563A1 (en) 1995-03-08
MX9302924A (es) 1993-11-01
EP0641563A4 (en) 1995-04-19
PL306093A1 (en) 1995-02-20
HU9403321D0 (en) 1995-02-28
CN1084061A (zh) 1994-03-23
HUT71250A (en) 1995-11-28
PL171704B1 (pl) 1997-06-30

Similar Documents

Publication Publication Date Title
AU6264994A (en) A method for the preparation of aqueous solutions containing performic acid as well as their use
AU5226796A (en) Water insoluble derivatives of polyanionic polysaccharides
NZ324446A (en) Pharmaceutical composition containing (e)-3,5-dihydroxy-7-[4'-4"-fluorophenyl-2'-cyclopropyl-quinolin -3'-yl]-6-heptenoic acid where the aqueous solution or dispersion of the composition has a ph of 7 to less than 8
AU564405B2 (en) Production of stabilized whey protein product
CA2007181A1 (en) Sustained Release Pharmaceutical Composition
AU6194998A (en) Aqueous cosmetic composition containing stably solubilized uric acid and water-soluble polymer and method for stably solubilizing uric acid in aqueous cosmetic composition
AU8202087A (en) 2beta-substituted-methylpenicillanic acid derivatives, and salts and esters thereof
AU590537B2 (en) Method for producing foamable compositions
IE791593L (en) Acid addition salts of dipiperidinoandrostanes
AU5405790A (en) Electrodialytic water splitting process for the treatment of aqueous electrolytes
BG99197A (en) Means for the treatment of cataract and method for its preparation
AU3331889A (en) 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases
IE821668L (en) Benzothiazolesulfonamide derivatives
HUT58048A (en) Process for producing 3,3'-dithio-bis(propionic acid) derivatives and their esters, as well as pharmaceutical compositions comprising same
ES2066134T3 (es) Usos farmaceuticos de acidos grasos.
IE801095L (en) Preparing pyrenzepine
GR3023194T3 (en) Imidazole substituted phenylaceticacidprolinzamide derivatives.
CA2132745A1 (en) Novel Cardioprotective Agents
TW334437B (en) Process for the preparation of streptogramins
HK57893A (en) Asymmetric synthesis of furo[3,4-c]pyridine derivatives
AU7250787A (en) A method for antagonizing the action of progesterone by administering an effective amount of 17 -ethynyl- 17 -acetoxy- 5 -androst- 2 -ene
WO1991005457A3 (en) Method of treating wintergreen flavors so as to eliminate undesirable offnotes associated therewith
HUT52961A (en) Process for production of watery doxorubicin solutions
EP0389773A3 (de) Verfahren zur Herstellung einer Galenischen Zubereitung mit optimaler Bioverfügbarkeit des Wirkstoffs 2-Hydroxy-5-methyllaurophenonoxime (HMLO)
DE3467341D1 (en) Cyclohexane carboxylic acids and derivatives thereof as antidysrhythmic agents